SCHEMBL12808401

SCHEMBL12808401

CNC(=O)[C@@]12C[C@H]1/C=C\CCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N1CCC[C@H]1C(=O)N2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ F2 P00734 1/20 0.35
▸ F10 P00742 1/20 0.35
▸ PRSS1 P07477 1/20 0.35
▸ XIAP P98170 2/20 0.33
▸ BIRC3 Q13489 2/20 0.33
▸ BIRC2 Q13490 2/20 0.33
▸ GAA P10253 3/20 0.33
▸ CYP3A4 P08684 2/20 0.32
▸ CTSB P07858 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ FPR2 P25090 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ NFKB2 Q00653 1/20 0.30
▸ RELA Q04206 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11984181 0.93 ADRB3 (0.36) ADRB3ADRA2BADRA2CF2F10
SCHEMBL11984121 0.92 GAA (0.36) ADRB3ADRA2BADRA2CF2F10
SCHEMBL13059758 0.92 GAA (0.36) ADRB3ADRA2BADRA2CF2F10
SCHEMBL7999967 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10
SCHEMBL8378473 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10
SCHEMBL1645865 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10
SCHEMBL1645862 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10
SCHEMBL13059226 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10
SCHEMBL8237408 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10
SCHEMBL1645860 0.92 ADRB3 (0.42) ADRB3ADRA2BADRA2CF2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299021-B2 Macrocyclic inhibitors of hepatitis C virus replication INTERMUNE, INC. (US) 2012-10-30 — — US disclosed
EP-2305697-A2 Macrocyclic inhibitors of Hepatitis C virus replication Intermune, Inc. (US) 2011-04-06 — — EP disclosed
Send feedback